Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuna Mutis

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Nature Medicine|April 3, 2002
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigensAnne M Dickinson, Xiao-Nong Wang, Lisbet Sviland, et al.
Haematologica|December 30, 2020
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricideMark Gurney, Arwen Stikvoort, Emma Nolan, et al.
Immunological Reviews|February 12, 2016
Monoclonal antibodies targeting CD38 in hematological malignancies and beyondNiels W C J van de Donk, Maarten L Janmaat, Tuna Mutis, et al.
Cancers|June 2, 2021
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma PatientsKristine A Frerichs, Christie P M Verkleij, Meletios A Dimopoulos, et al.
Haematologica|December 17, 2014
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomideInger S Nijhof, Jeroen J Lammerts van Bueren, Berris van Kessel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Eradication of medullary multiple myeloma by CD4+ cytotoxic human T lymphocytes directed at a single minor histocompatibility antigenRobbert M Spaapen, Richard W J Groen, Kelly van den Oudenalder, et al.
Oncotarget|November 23, 2020
T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myelomaChristie P M Verkleij, Kristine A Frerichs, Marloes Broekmans, et al.
Blood|December 10, 2009
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilizationJorg van Loosdregt, Yvonne Vercoulen, Teun Guichelaar, et al.
Haematologica|May 22, 2008
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effectHenk Rozemuller, Ellen van der Spek, Lijnie H Bogers-Boer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T CellsEsther Drent, Renée Poels, Ruud Ruiter, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Nature Medicine|April 3, 2002
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigensAnne M Dickinson, Xiao-Nong Wang, Lisbet Sviland, et al.
Haematologica|December 30, 2020
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricideMark Gurney, Arwen Stikvoort, Emma Nolan, et al.
Immunological Reviews|February 12, 2016
Monoclonal antibodies targeting CD38 in hematological malignancies and beyondNiels W C J van de Donk, Maarten L Janmaat, Tuna Mutis, et al.
Cancers|June 2, 2021
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma PatientsKristine A Frerichs, Christie P M Verkleij, Meletios A Dimopoulos, et al.
Haematologica|December 17, 2014
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomideInger S Nijhof, Jeroen J Lammerts van Bueren, Berris van Kessel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Eradication of medullary multiple myeloma by CD4+ cytotoxic human T lymphocytes directed at a single minor histocompatibility antigenRobbert M Spaapen, Richard W J Groen, Kelly van den Oudenalder, et al.
Oncotarget|November 23, 2020
T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myelomaChristie P M Verkleij, Kristine A Frerichs, Marloes Broekmans, et al.
Blood|December 10, 2009
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilizationJorg van Loosdregt, Yvonne Vercoulen, Teun Guichelaar, et al.
Haematologica|May 22, 2008
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effectHenk Rozemuller, Ellen van der Spek, Lijnie H Bogers-Boer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T CellsEsther Drent, Renée Poels, Ruud Ruiter, et al.
Pageof 11